International Niemann–Pick Disease Alliance

Xenpozyme (olipudase alfa) approved by FDA as first disease-specific treatment for ASMD (non-CNS manifestations)

Join the Registry

Calling all patients and carers! We've created a global registry of all NPD patients - if you're not enrolled yet, join us now...

The Impact of NPC

The global community tell their stories...